scispace - formally typeset
F

Francesca Zimetti

Researcher at University of Parma

Publications -  81
Citations -  2079

Francesca Zimetti is an academic researcher from University of Parma. The author has contributed to research in topics: Cholesterol & Internal medicine. The author has an hindex of 21, co-authored 55 publications receiving 1462 citations.

Papers
More filters
Journal ArticleDOI

Increased Atherosclerosis in Mice Lacking Apolipoprotein A-I Attributable to Both Impaired Reverse Cholesterol Transport and Increased Inflammation

TL;DR: It is concluded that apoA-I inhibits atherosclerosis by promoting both macrophage reverse cholesterol transport and HDL antiinflammatory function, and that these anti-atherogenic functions of apo-I are largely independent of the plasma level of HDL-C in this mouse model.
Journal ArticleDOI

Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis

TL;DR: Although some polyphenols might improve specific markers of cardiovascular risk and cognitive status, many inconsistent data are present in literature, therefore, definitive recommendations for the use of these compounds in the prevention of cardiovascular disease and cognitive decline are currently not applicable.
Journal ArticleDOI

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus

TL;DR: In this paper, the capacity of high-density lipoproteins (HDL) to promote cell cholesterol efflux is investigated in rheumatoid arthritis (RA) and systemic lupus erythemathosus (SLE) patients.
Journal ArticleDOI

Probucol Inhibits ABCA1-Mediated Cellular Lipid Efflux

TL;DR: Probucol is an effective inhibitor of ABCA1-mediated cholesterol efflux without influencing scavenger receptor class B type I–mediated efflux, which may in part explain the reported in vivo high-density lipoprotein–lowering action of probucol.
Journal ArticleDOI

Depletion of Pre-β-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein

TL;DR: The results indicate that chymase treatment of HDL3 specifically impairs the ABCA1-dependent pathway without influencing either aqueous or SR-BI-facilitated diffusion and that this effect is caused by depletion of lipid-poor pre-β-migrating particles in HDL3.